NR3C2 and hydrops fetalis: Medications including angiotensin-converting enzyme and angiotensin receptor-neprilysin inhibitors, β-blockers, and mineralocorticoid receptor antagonists, could significantly lower all-cause and cardiovascular mortality, as well as all-cause and HF-related hospitalization rates among HF sufferers (5).